Formulations of zero-order, pH-dependent, sustained release matrix systems by ionotropic gelation of alginate-containing mixtures

References

• FMC product brochure ‘Alginates for Pharmaceutical Applications’ (2010) for basic information including regulatory status on alginates.
   Google Scholar
• Murillo-Alvarez JI, Hernandez-Carmona G. (2007). Monomer composition and sequence of sodium alginate extracted at pilot plant scale from three commercially important seaweeds from Mexico. J Appl Phycol, 19:545–8.
   Web of Science ®Google Scholar
• Chhatbar M, Meena R, Prasad K, Siddhanta AK. (2009). Microwave assisted rapid method for hydrolysis of sodium alginate for M/G ratio determination. Carb Polym, 76:650–6.
   Web of Science ®Google Scholar
• McDowell RH. (1986). Properties of alginates. 5th ed. London: Kelco International.
   Google Scholar
• Hebrard G, Hoffart V, Cardot JM, Subirade M, Alric M, Beyssac E. (2009). Investigation of coated whey protein/alginate beads as sustained release dosage form in simulated gastrointestinal environment. Drug Dev Ind Pharm, 35(9):1103–12.
   PubMed Web of Science ®Google Scholar
• Braccini I, Perez, S. (2001). Molecular basis of Ca2+ Induced gelation in alginates and pectins: The egg-box model revisited. Biomacromolecules, 2:1089–96.
   PubMed Web of Science ®Google Scholar
• McClement DJ. (2006). Non-covalent interactions between proteins and polysaccharides. Biotechnol Adv, 24:621–5.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Takayaa K, Machida Y, Nagai T. (1990). Characterization of polyion complexes of chitosan with sodium alginate and sodium polyacrylate. Int J Pharm, 61:35–41.
   Web of Science ®Google Scholar
• Moustafine RI, Salachove AI, Frolova ES, Kemenova VA, Van den Mooter G. (2009). Interpolyelectrolyte complex of Eudragit® EPO with sodium alginate as potential carrier for colonic drug delivery: Monitoring of structural transformation and composition charges during swellability and release evaluating. Drug Dev Ind Pharm, 35(12):1439–51.
   PubMed Web of Science ®Google Scholar
• Tonnesen HH, Karlsen J. (2002). Alginate in drug delivery systems. Drug Dev Ind Pharm, 28:621–30.
   PubMed Web of Science ®Google Scholar
• Hodson AC, Mitchell JR, Davies MC, Melia CD. (1995). Structure and behavior in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained release performances and internal gel structure of sodium alginate matrices. J Control Rel, 33:143–52.
   Web of Science ®Google Scholar
• Liew CV, Chan LW, Ching AL, Heng PWS. (2006). Evaluation of sodium alginate as drug release modifier in matrix tablets. Int J Pharm, 309:25–37.
   PubMed Web of Science ®Google Scholar
• Kubo W, Miyazaki S, Atwood D. (2003). Oral sustained delivery of paracetamol from in-situ gelling gellan and sodium alginate formulations. Int J Pharm, 258:55–64.
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Kubo W, Attwood D. (2000). Oral sustained delivery of theophylline using in-situ gelation of sodium alginate. J Control Release, 67:275–80
   PubMed Web of Science ®Google Scholar
• Itoh K, Tsuruya R, Shimoyama T, Watanabe H, Miyazaki S, D'Emanuele A, . (2010). In-situ gelling xyloglucan/alginate liquid formulation for oral sustained drug delivery to dysphagic patients. Drug Dev Ind. Pharm, 36(4):449–55.
   PubMed Web of Science ®Google Scholar
• Stockwell AF, Davis SS. (1986). In-vitro evaluation of alginate gel systems. J Contr Rel, 3:167–75.
   Google Scholar
• Gutsche S, Krause M, Kranz H. (2008). Strategies to overcome pH‐dependent solubility of weakly basic drugs by using different types of alginates. Drug Dev Ind Pharm, 34:1277–84.
   PubMed Web of Science ®Google Scholar
• Timmins P, Delargy A.M., Howard JR, Rowlands EA. (1991). Evaluation of the granulation of a hydrophylic matrix sustained release tablet. Drug Dev Ind Pharm, 17:531–50.
   Web of Science ®Google Scholar
• Cekc ND, Milic JM, Savic SD, Savic MM, Jovic Z, Daniels R. (2009). Influence of the preparation procedure and chitosan type on physicochemical properties and release behavior of alginate-chitosan microparticles. Drug Dev Ind Pharm, 35(9):1092–1102.
   PubMed Web of Science ®Google Scholar
• Drefko W, Moroni A. (2001). Applications of alginate mixtures as pH dependent sustained release systems. Proceedings of the 28th Symposium Control Release Bioact Mater, Abstract #6074, San Diego, CA, June 23–27.
   Google Scholar
• Moroni A, Drefko W. (2002). Applications of alginate mixtures as pH dependent sustained release systems II. Proceedings of the 29th Symposium Control Release Bioact Mater, Abstract #577, Seoul, Korea, July 21–25.
   Google Scholar
• Moroni A, Drefko W. (2002). pH-dependent sustained release, drug delivery compositions. US patent application 6,465,014 B1.
   Google Scholar
• Kranz H, Guthmann C, Wagner T, Lipp R, Reinhard J. (2005). Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug. Eur J Pharm Sci, 26:47–53.
   PubMed Web of Science ®Google Scholar
• Zhang SQ, Rahman Z, Thumma S, Repka MA, Chen GH, Li SM. (2009). Development and evaluation of a pH-dependent sustained release tablet for irritable bowel syndrome. Drug Dev Ind Pharm, 35:57–64.
   PubMed Web of Science ®Google Scholar